Plain-English translation of NCT06506188 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The LINK study is testing a new way to help breastfeeding mothers in Malawi who are taking PrEP (a medicine that prevents HIV infection) stay on their treatment and get the support they need. The study combines HIV testing, risk screening, partner support, and peer counseling all in one place — during routine baby vaccination visits — to make it easier for mothers to access care without extra trips.
Many breastfeeding mothers in Malawi are at risk for HIV, but they often stop taking their prevention medicine or miss follow-up appointments because they're busy caring for newborns. This study exists to see if connecting HIV prevention services to baby vaccination appointments — something mothers are already doing — can help them stay on treatment and protected.
You likely qualify if…
You likely don't qualify if…
Depending on your role, you might share your health records from clinic visits, complete a survey about your experience with PrEP and support, or donate a small blood sample from a fingerstick. Some participants may be invited for a longer interview to share their story in more detail. Your clinic will continue to provide all regular HIV testing, PrEP care, and baby vaccination services as usual — the study simply adds extra support and gathers information about how well the new integrated model works.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Malawi